Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Trial update-sites added
View:
Post by 1ottrunner on Jul 13, 2021 8:25am

Trial update-sites added

https://clinicaltrials.gov/ct2/history/NCT04504734?A=27&B=28&C=merged#StudyPageTop
Comment by TheTerminator1 on Jul 13, 2021 8:30am
WOW.....that's 7 new clinical sites I am impressed !
Comment by 1ottrunner on Jul 13, 2021 8:44am
Hopefully these sites have been active for a few weeks and they are simply updating late. I've seen posts on the FB group proclaiming that no new sites is an obvious positive sign, I wonder what sign it is now? The trial stipend must be pitiful.  Imagine if investors had funded this trial for 20 million dollars, that's right, we did! The trial must have positive data or I'm ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities